Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.21.69: Protein C (activated)

This is an abbreviated version!
For detailed information about Protein C (activated), go to the full flat file.

Word Map on EC 3.4.21.69

Reaction

degradation of blood coagulation factors Va and VIIIa =

Synonyms

Activated blood coagulation factor XIV, Activated protein C, anticoagulant activated protein C, anticoagulant protein C/protein S system, anticoagulant serine protease-activated protein C, anticoagulant-activated protein C, APC, Autoprothrombin II-A, Autoprothrombin IIA, Blood coagulation factor XIV, Blood-coagulation factor XIV, activated, Blood-coagulation factor XIVa, ghrelin endopeptidase, GSAPC, hAPC, PROC, Protein Ca, rhAPC

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.21 Serine endopeptidases
                3.4.21.69 Protein C (activated)

Activating Compound

Activating Compound on EC 3.4.21.69 - Protein C (activated)

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
certoparin
-
clinical LMWH enhances activity
-
cholesterol
-
in phosphatidylcholine/phosphatidylserine vesicles, cholesterol enhances Factor Va inactivation and the rate of cleavage by enzyme both at R506 and R306
dalteparin
-
clinical LMWH enhances activity
-
dermatan sulfate
endothelial cell protein C receptor
activation of protein C is potentiated by the presence of the endothelial cell protein C receptor (EPCR), which binds protein C with high affinity and increases the rate of protein C activation by about 20fold in vivo
-
enoxaparin
-
clinical LMWH enhances activity
factor Xa
-
stimulates factor Va cleavage at Arg306, but inhibits the cleavage at Arg506 20fold, overview, factor Xa and protein S interact with distinct sites on factor Va
-
glycosaminoglycan
-
enhances activity with factor V but not with factor Va as substrate
LMW heparin
-
enhances the anticoagulant action of activated protein C
-
nadroparin
-
clinical LMWH enhances activity
-
phosphatidylcholine
-
as phospholipid vesicles with 80% phosphatidylcholine and 20% phosphatidylserine, specific binding to the enzyme of anionic phospholipid vesicles passed over the protein C surface, defective phospholipid binding of mutant variants also resulted in severely impaired anticoagulant activity in protein C-deficient plasma
phosphatidylserine
-
as phospholipid vesicles with 80% phosphatidylcholine and 20% phosphatidylserine, specific binding to the enzyme of anionic phospholipid vesicles passed over the protein C surface, defective phospholipid binding of mutant variants also resulted in severely impaired anticoagulant activity in protein C-deficient plasma
Phospholipid
Phospholipids
-
-
polysulfated dermatan sulfate
-
more active than dermatan sulfate-derived oligosaccharide on basis of comparable molecular weight. Most active polysulfated dermatan sulfate has a molecular weight of 2749 and increases enzyme activity by about 230%
-
ProTac
-
protein S
-
tinzaparin
-
clinical LMWH enhances activity
-
vitamin K
additional information
-